Stockscreener 앱 받기
1.01
15.83%
-0.19
시간 외 거래:
1.01
전일 마감가:
$1.20
열려 있는:
$1.2
하루 거래량:
24,920
Relative Volume:
0.19
시가총액:
$7.19M
수익:
-
순이익/손실:
$-50.18M
주가수익비율:
-0.1224
EPS:
-8.2506
순현금흐름:
$-45.31M
1주 성능:
+140.48%
1개월 성능:
-45.11%
6개월 성능:
-82.74%
1년 성능:
-87.53%
1일 변동 폭
$0.90
$1.20
1주일 범위
$0.70
$1.24
52주 변동 폭
$0.35
$13.75
바이케리어스 서지컬 Stock (RBOT) Company Profile
명칭
Vicarious Surgical Inc
전화
(617) 868-1700
주소
78 FOURTH AVENUE, WALTHAM
Compare RBOT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
1.01 | 13.67M | 0 | -50.18M | -45.31M | -8.2506 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
바이케리어스 서지컬 Stock (RBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 개시 | Credit Suisse | Outperform |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-11-05 | 개시 | Canaccord Genuity | Buy |
| 2021-10-18 | 개시 | BTIG Research | Buy |
| 2021-10-07 | 개시 | Piper Sandler | Overweight |
모두보기
바이케리어스 서지컬 주식(RBOT)의 최신 뉴스
Vicarious Surgical sees FY2026 cash burn of $35 million - MSN
Vicarious Surgical applies for Nasdaq listing - MedTech Dive
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing - Ortho Spine News
Vicarious Surgical announces strategic plan to pursue Nasdaq listing - marketscreener.com
Vicarious Surgical Announces Strategic Plan To Pursue Nasdaq Listing - TradingView
Reverse split proposal aims to relist Class A shares (RBOT) on Nasdaq - Stock Titan
ETFs Investing in Vicarious Surgical, Inc. Class A Stocks - TradingView
Non-controlling/minority interest of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Discontinued operations of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Operating expenses (excl. COGS) of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Preferred dividends of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Dilution adjustment of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Diluted shares outstanding of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Total operating expenses of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Vicarious Surgical Inc. Income Statement – OTC:RBOT - TradingView
The Technical Signals Behind (RBOT) That Institutions Follow - Stock Traders Daily
Vicarious Surgical System: Next-Generation Single-Port Robotic Surgery Platform, FDA Pathway, and Market Strategy Overview - Minichart
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results - Ortho Spine News
Vicarious Surgical Delisted to OTC as Losses Narrow - TipRanks
NYSE delists Vicarious Surgical (RBOT); 2025 net loss totals $50M - Stock Titan
Vicarious Surgical projects cash burn drop from $45.1M to $19M - Stock Titan
Aug Weekly: Is Vicarious Surgical Inc Equity Warrant stock undervalued right nowEarnings Risk Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
Vicarious Surgical Inc.(OTCPK: RBOT) dropped from S&P TMI Index - marketscreener.com
Vicarious Surgical Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Will Vicarious Surgical Inc. Equity Warrant stock deliver strong dividend growthPortfolio Value Summary & Free Accurate Trade Setup Notifications - Naître et grandir
Weekly Earnings: What is Vicarious Surgical Incs valuation compared to sectorProduct Launch & Community Supported Trade Ideas - baoquankhu1.vn
Wall Street Recap: Can Vicarious Surgical Inc be the next market leaderPortfolio Gains Summary & Capital Protection Trade Alerts - baoquankhu1.vn
Vicarious Surgical Implements Executive Salary Reductions, Maintains Incentives - TipRanks
Stock Market Recap: Will Vicarious Surgical Inc Equity Warrant outperform its industry peersEarnings Risk Report & Weekly Top Gainers Trade List - baoquankhu1.vn
Levels Update: Can Vicarious Surgical Inc be recession proofDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
EBITDA margin % of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Vicarious Surgical Inc. Balance Sheet – OTC:RBOT - TradingView
CapEx per share of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Vicarious Surgical, Inc. Class A Financial Disclosures & SEC Filings - TradingView
Quick ratio of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Basic earnings per share (basic EPS) of Vicarious Surgical Inc. – OTC:RBOT - TradingView
RBOT Forecast — Price Target — Prediction for 2027 - TradingView
RBOT Stock Price and Chart — OTC:RBOT - TradingView
Vicarious Surgical Inc.(OTCPK:RBOT) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Vicarious Surgical receives delisting notice from NYSE - Medical Buyer
Vicarious Surgical Inc.(OTCPK: RBOT) dropped from Russell Microcap Growth Index - marketscreener.com
Vicarious Surgical stock to move to OTC market after NYSE delisting - Investing.com Australia
Vicarious Surgical receives NYSE delisting notice - MedTech Dive
Vicarious Surgical at Risk of NYSE Delisting - Medical Product Outsourcing
Vicarious Surgical Announces NYSE Delisting and OTC Transition - TipRanks
Vicarious Surgical stock to move to OTC market after NYSE delisting By Investing.com - Investing.com UK
Vicarious Surgical Received Notice of Delisting - TradingView
Vicarious Surgical (RBOT) hit with NYSE delisting, shifts trading to OTCID - Stock Titan
Surgery robot startup faces NYSE delisting, plans OTC trading next - Stock Titan
Nyse to commence delisting proceedings against Vicarious Surgical Inc. (RBOT) - marketscreener.com
NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT) - FinancialContent
바이케리어스 서지컬 (RBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):